Email this article Gemcitabine (Citochem) in the treatment of advanced transitional cell bladder cancer
- Authors: Matveyev V.B.1, Volkova M.I.1
-
Affiliations:
- State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences
- Issue: Vol 4, No 4 (2008)
- Pages: 74-79
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER
- Published: 30.12.2008
- URL: https://oncourology.abvpress.ru/oncur/article/view/1048
- DOI: https://doi.org/10.17650/1726-9776-2008-4-4-74-79
- ID: 1048
Cite item
Full Text
Abstract
Citochem is an effective and safe medication: main active substrate of the agent is gemcitabine. Citochem in combination with cisplatin provides satisfactory efficacy without high toxicity of treatment in patients with advanced transitional cell bladder cancer and can be recommended for use in clinical practice of oncourology.
About the authors
V. B. Matveyev
State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences
Author for correspondence.
Department of urology
Moscow
Russian FederationM. I. Volkova
State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences
Department of urology
Moscow
Russian FederationReferences
Supplementary files
